Draft EU merger guidelines introducing a 'theory of benefit' framework are likely to be formally adopted later in 2026, reshaping how companies justify deals to the European Commission
The European Commission published draft merger assessment guidelines on 30 April 2026 that are expected to be adopted later this year. The guidelines introduce a 'theory of benefit' framework that will allow companies to cite factors such as innovation, resilience, and sustainability as justifications for proposed mergers — a significant shift in how the Commission balances potential anti-competitive effects from a deal against the efficiencies it may generate. McGuireWoods London partner Matthew Hall commented that the new framework will make it easier for merging parties to argue the case for clearance on broader public-interest grounds beyond conventional price and market-share analysis. The Commission's approach represents a meaningful evolution from its previous stance, under which efficiency defences were rarely decisive in contentious cases. The guidelines sit within the existing EU merger control framework administered by the Commission's Directorate-General for Competition (DG COMP). They are not a legislative instrument but rather guidance on how the Commission will apply its existing analytical tools — meaning they do not require Parliamentary approval but will nonetheless carry significant practical weight for deal teams advising on transactions with a European dimension. For UK practitioners advising on cross-border deals, the interplay between the Commission's revised approach and the Competition and Markets Authority (CMA)'s own merger assessment framework remains a live coordination question.
Why this matters
The introduction of a structured 'theory of benefit' analysis alongside anti-competitive effects assessment marks the most significant evolution in EU merger methodology in years. For deal teams, it creates both an opportunity — additional grounds to argue for clearance — and a burden: parties will need to prepare detailed, evidence-based benefit submissions as a standard part of merger filings, not merely as a last resort. This directly expands the scope of phase one and phase two merger control workstreams. UK firms advising on EU-nexus deals will need to develop expertise in preparing innovation, resilience, and sustainability benefit arguments for DG COMP, while also tracking whether the CMA adopts analogous approaches in domestic reviews.
On the Ground
A trainee on an EU merger control matter would assist with regulatory notification drafting — preparing Form CO submissions — and compile compliance gap analysis memos comparing the transaction's competitive effects against the Commission's new benefit framework. They would also coordinate local counsel instructions across EU member state jurisdictions where national merger filings are required.
Interview prep
Question you might get
“How does the European Commission's new 'theory of benefit' framework change the strategic approach to a phase two EU merger investigation?”
Sign up free to see the full answer
A model answer you can lift into an interview — how to frame this story for a partner.
Sign up freeMy notes
saved